Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
File results
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer
-
FOI/2023/0957 - Maternity services intervention statistics; still birth, elective C-section, emergency C-section
-
FOI/2023/0961 - Robotic Process Automation staff details
-
FOI/2024/0001 - Intrathecal therapy services/ spasticity service
-
FOI/2024/0003 - Translation, interpretation and language service costs - 2019/20 to 2022/2023
-
FOI/2024/0009 - Electronic Patient Record (EPR) and Medical Device Integration (MDI) solution
-
FOI/2024/0012 - Paediatric asthma wait time and referrals
-
FOI/2024/0013 - Medications within dermatology and respiratory medicine
-
FOI/2024/0017 - Assault attendances to Emergency Department 2023